Gene-edited therapy BE-CAR7 represents a monumental breakthrough in cancer treatment, achieving 82% deep remission rates for previously incurable T-cell leukemia. This off-the-shelf treatment uses base editing to transform donor immune cells into cancer-fighting weapons, offering real hope where only palliative care existed before.